Roche
ROG.SW
#35
Rank
NZ$574.85 B
Marketcap
NZ$716.55
Share price
1.38%
Change (1 day)
48.85%
Change (1 year)

EPS for Roche (ROG.SW)

EPS in 2023: NZ$29.32

According to Roche's latest financial reports the company's current EPS (TTM) is NZ$29.32. In 2023 the company made an earnings per share (EPS) of NZ$29.32 an increase over its 2022 EPS that were of NZ$28.76.

EPS history for Roche from 1998 to 2023

Annual EPS

Year EPS Change
2023NZ$29.321.95%
2022NZ$28.76-6.29%
2021NZ$30.69-5.53%
2020NZ$32.4916.56%
2019NZ$27.8730.3%
2018NZ$21.3920.22%
2017NZ$17.79-5.81%
2016NZ$18.894.62%
2015NZ$18.05-5.13%
2014NZ$19.03-25.05%
2013NZ$25.3921.73%
2012NZ$20.863.82%
2011NZ$20.098.16%
2010NZ$18.5723.72%
2009NZ$15.01-12.31%
2008NZ$17.12-0.34%
2007NZ$17.1832.13%
2006NZ$13.0042.56%
2005NZ$9.12-22.7%
2004NZ$11.80132.85%
2003NZ$5.07-148.96%
2002NZ-$10.35-209.09%
2001NZ$9.49-57.25%
2000NZ$22.1954.06%
1999NZ$14.4031.24%
1998NZ$10.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$17.87-39.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.00-55.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.94-89.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$6.34-78.36%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
NZ$12.60-57.03%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
NZ$6.16-79.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Abbott Laboratories
ABT
NZ$13.79-52.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$22.30-23.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$9.53-67.48%๐Ÿ‡บ๐Ÿ‡ธ USA